Search results
Order by most recent / most popular / relevance
Results: 1-10 of 29
NASDAQ Biotechnology Index surpasses all-time high in 1Q13
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 16 2013
The NASDAQ Biotechnology Index reportedly rose in the first quarter of 2013 (1Q13) above levels last seen during the 2000 genomics bubble peakthe
Cincinnati investor closes $4.4 million fund to invest in startups
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 30 2011
Cincinnati-based CincyTech, a venture development company that invests in startup biotech, information technology and advanced manufacturing businesses, has announced the closing of a $4.4 million Fund II targeted for 10 to 12 new startups in southwest Ohio
Biotech investments rise in Q4 2012, but remain off for the year
- Shook Hardy & Bacon LLP
- -
- USA
- -
- January 24 2013
Pricewatershouse Coopers LLP has released its fourth quarter (Q4) and final 2012 venture capital investment reports and notes that "Biotechnology
New program to provide accelerated “speed-to-market” for medical device entrepreneurs
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 1 2012
The nonprofit Memphis Bioworks Foundation and Innova, a pre-seed, seed and early-stage investor, have announced a program designed to help entrepreneurs bring medical device products and companies to market
Court upholds drug profit sharing; pharma co. breached agreement to negotiate deal
- Shook Hardy & Bacon LLP
- -
- USA
- -
- June 7 2012
A Delaware court has issued a letter opinion finalizing its 2011 ruling requiring SIGA Technologies Inc. to share profits from its smallpox drug with PharmAthene, Inc. PharmAthene, Inc. v. SIGA Techs, Inc., No. 267-VCP (Del. Ch., decided May 31, 2012
North Carolina life sciences companies attract more than $1.1 billion in investments, grants
- Shook Hardy & Bacon LLP
- -
- USA
- -
- May 19 2011
After conducting its yearly survey of media reports, a North Carolina trade association has announced that life sciences companies brought in more than $1.1 billion in investments and grants to the state in the 12 months ending April 25, 2011, representing a 25 percent increase over the 12-month period ending April 2010
Barbados launches biotech initiative designed to shorten R&D process
- Shook Hardy & Bacon LLP
- -
- Barbados
- -
- December 16 2010
The Barbados government has recently launched two initiatives to attract biotech companies to the island nation
Medicinova and Zhejiang Medicine announce joint venture in China
- Shook Hardy & Bacon LLP
- -
- China, USA
- -
- March 10 2011
California-based biopharmaceutical company MediciNova Inc. and Zhejiang Medicine Co., a Chinese pharmaceutical manufacturer, have announced a joint venture to develop and commercialize MediciNova’s MN-221 in China
Agilent Technologies acquires BIOCIUS Life Sciences
- Shook Hardy & Bacon LLP
- -
- USA
- -
- March 10 2011
California-based Agilent Technologies has announced the acquisition of BIOCIUS Life Sciences, a Massachusetts-based company that developed a spectrometry device, enabling "researchers to gain a fuller understanding of a drug's biochemical properties, including potential liabilities in drug interactions
Chinese billionaire backs U.S.China biopharma venture
- Shook Hardy & Bacon LLP
- -
- China, USA
- -
- April 21 2011
Chinese real-estate billionaire Qi Jinzing has reportedly begun investing in the biotech sector despite its potential financial risks
Current Search
- Author - Madeleine McDonough
- Author - Thomas T. Moga
- Workarea - Corporate Finance/M&A
- Workarea - Healthcare